Position in URGN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,190,480
+$849,040 QoQ
Shares Held
32,350
+70.4% QoQ
Ownership
0.066%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#74
of 190 holders
Holding Since
Jun 2020
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in URGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ALGERT GLOBAL LLC holds $633,232,925 across 110 Biotechnology names. URGN ranks #74 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PCVX |
Vaxcyte, Inc.
|
515,343 | $29,956,888 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
845,118 | $29,908,726 | |
| 3 | XENE |
Xenon Pharmaceuticals Inc.
|
419,773 | $25,337,498 | |
| 4 | CLDX |
Celldex Therapeutics, Inc.
|
647,836 | $24,105,977 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
95,335 | $23,335,147 | |
| 6 | SNDX |
Syndax Pharmaceuticals Inc
|
1,051,465 | $22,985,024 | |
| 7 | MRNA |
Moderna, Inc.
|
274,820 | $19,245,644 | |
| 8 | MLYS |
Mineralys Therapeutics, Inc.
|
649,027 | $17,510,748 |
All Filings in URGN
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,190,480 | 32,350 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $341,440 | 18,990 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $1,544,197 | 65,935 | Shares | Sole | 2026-02-17 | |
| 2022-06-30 | $84,766 | 10,350 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $91,803 | 10,540 | Shares | Sole | 2022-05-16 | |
| 2021-03-31 | $226,552 | 11,630 | Shares | Sole | 2021-05-14 | |
| 2020-06-30 | $284,185 | 10,880 | Shares | Sole | 2020-08-12 | |
| No filing history on record for this holder in this stock. | ||||||